Nephropathy in SIV-Infected Macaques During Antiretroviral Therapy
Author Information
Author(s): Brigitte E Sanders-Beer, Yvette Y Spano, Dawn Golightly, Abigail Lara, Diane Hebblewaite, Lourdes Nieves-Duran, Lowrey Rhodes, Keith G Mansfield
Primary Institution: Southern Research Institute
Hypothesis
What are the clinical and biochemical correlates of nephropathy in SIV-infected macaques receiving high-dose antiretroviral therapy?
Conclusion
The study found that morphologic evidence of nephropathy was common in SIV-infected macaques receiving high-dose ART, but acute renal failure was rare.
Supporting Evidence
- Acute renal failure was uncommon, occurring in only 7.1% of treated animals.
- Morphologic evidence of nephropathy persisted for more than 300 days after treatment.
- Biochemical changes in BUN and phosphorus correlated with disease severity.
Takeaway
When macaques with SIV were treated with high doses of certain medications, many showed signs of kidney problems, but very few had serious kidney failure.
Methodology
The study involved administering high-dose ART to SIV-infected macaques and monitoring their health through biochemical and histological evaluations.
Potential Biases
Potential bias may arise from the specific selection of macaques and the treatment regimen used.
Limitations
The study was limited by the small sample size and the inability to predict acute renal failure based on serum chemistry values.
Participant Demographics
All participants were male Indian-origin rhesus macaques.
Statistical Information
P-Value
0.0008
Confidence Interval
95% CI -0.7964 to -0.1079
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website